Eisai and Biogen have been testing whether a different form of Leqembi an undertheskin injection can be as safe and effective as the already marketed version. On Wednesday at a medical conference in Boston researchers presented results from a study of nearly 400 participants that suggests the two forms are roughly comparable. the clinical trial that initially led to Leqembis approval